mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |